Viridian Therapeutics, Inc./DE
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 203.1M |
| FY2018 | 277.6M |
| FY2019 | 20.9M |
| FY2020 | 32.0M |
| FY2021 | 35.8M |
| FY2022 | 32.1M |
| FY2023 | 44.8M |
| FY2024 | 81.0M |
| FY2025 | 101.8M |
| FY2026 | 102.2M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 203.1M |
| FY2018 | 277.6M |
| FY2019 | 20.9M |
| FY2020 | 32.0M |
| FY2021 | 35.8M |
| FY2022 | 32.1M |
| FY2023 | 44.8M |
| FY2024 | 81.0M |
| FY2025 | 101.8M |
| FY2026 | 102.2M |